Selected research
Industry Research
Heparin Sodium Injection Industry Research Report 2026
Market perspective
The global Heparin Sodium Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Heparin Sodium Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Heparin Sodium Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Heparin Sodium Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Heparin Sodium Injection include Sichuan Deebio, Shenzhen Hepalink, Nanjing King-friend, Pfizer, Changzhou Qianhong Bio-pharma, Baxter, Yino Pharma Limited, Xinbai Pharmaceuticals and Pharma Action, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Heparin Sodium Injection market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Heparin Sodium Injection Market by Company
Sichuan Deebio
Shenzhen Hepalink
Nanjing King-friend
Pfizer
Changzhou Qianhong Bio-pharma
Baxter
Yino Pharma Limited
Xinbai Pharmaceuticals
Pharma Action
Opocrin
Dongying Tiandong Pharmaceutical
Dongcheng Biochemicals
Changshan Biochemical
Bioibérica
Aspen Oss
Heparin Sodium Injection Segment by Type
1, 000 USP Units / mL
5, 000 USP Units / mL
10, 000 USP Units / mL
Heparin Sodium Injection Segment by Application
Cardioversion of Atrial Fibrillation/Flutter
Complications of Pregnancy
Treatment of Venous Thromboembolism
Other
Heparin Sodium Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Heparin Sodium Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Heparin Sodium Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Heparin Sodium Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Heparin Sodium Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Heparin Sodium Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Heparin Sodium Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 1, 000 USP Units / mL
- 5, 000 USP Units / mL
- 10, 000 USP Units / mL
Applications
- Cardioversion of Atrial Fibrillation/Flutter
- Complications of Pregnancy
- Treatment of Venous Thromboembolism
- Other
Companies covered
- Sichuan Deebio
- Shenzhen Hepalink
- Nanjing King-friend
- Pfizer
- Changzhou Qianhong Bio-pharma
- Baxter
- Yino Pharma Limited
- Xinbai Pharmaceuticals
- Pharma Action
- Opocrin
- Dongying Tiandong Pharmaceutical
- Dongcheng Biochemicals
- Changshan Biochemical
- Bioibérica
- Aspen Oss
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Heparin Sodium Injection Market Size (2021-2032)
- 2.2.2 Global Heparin Sodium Injection Sales (2021-2032)
- 2.2.3 Global Heparin Sodium Injection Market Average Price (2021-2032)
- 2.3 Heparin Sodium Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 1, 000 USP Units / mL
- 2.3.3 5, 000 USP Units / mL
- 2.3.4 10, 000 USP Units / mL
- 2.4 Heparin Sodium Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Cardioversion of Atrial Fibrillation/Flutter
- 2.4.3 Complications of Pregnancy
- 2.4.4 Treatment of Venous Thromboembolism
- 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Heparin Sodium Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Heparin Sodium Injection Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Heparin Sodium Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Heparin Sodium Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Heparin Sodium Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Heparin Sodium Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Heparin Sodium Injection, Product Type & Application
- 3.8 Global Manufacturers of Heparin Sodium Injection, Established Date
- 3.9 Global Heparin Sodium Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sichuan Deebio
- 4.1.1 Sichuan Deebio Company Information
- 4.1.2 Sichuan Deebio Business Overview
- 4.1.3 Sichuan Deebio Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Sichuan Deebio Heparin Sodium Injection Product Portfolio
- 4.1.5 Sichuan Deebio Recent Developments
- 4.2 Shenzhen Hepalink
- 4.2.1 Shenzhen Hepalink Company Information
- 4.2.2 Shenzhen Hepalink Business Overview
- 4.2.3 Shenzhen Hepalink Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Shenzhen Hepalink Heparin Sodium Injection Product Portfolio
- 4.2.5 Shenzhen Hepalink Recent Developments
- 4.3 Nanjing King-friend
- 4.3.1 Nanjing King-friend Company Information
- 4.3.2 Nanjing King-friend Business Overview
- 4.3.3 Nanjing King-friend Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Nanjing King-friend Heparin Sodium Injection Product Portfolio
- 4.3.5 Nanjing King-friend Recent Developments
- 4.4 Pfizer
- 4.4.1 Pfizer Company Information
- 4.4.2 Pfizer Business Overview
- 4.4.3 Pfizer Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Pfizer Heparin Sodium Injection Product Portfolio
- 4.4.5 Pfizer Recent Developments
- 4.5 Changzhou Qianhong Bio-pharma
- 4.5.1 Changzhou Qianhong Bio-pharma Company Information
- 4.5.2 Changzhou Qianhong Bio-pharma Business Overview
- 4.5.3 Changzhou Qianhong Bio-pharma Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Changzhou Qianhong Bio-pharma Heparin Sodium Injection Product Portfolio
- 4.5.5 Changzhou Qianhong Bio-pharma Recent Developments
- 4.6 Baxter
- 4.6.1 Baxter Company Information
- 4.6.2 Baxter Business Overview
- 4.6.3 Baxter Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Baxter Heparin Sodium Injection Product Portfolio
- 4.6.5 Baxter Recent Developments
- 4.7 Yino Pharma Limited
- 4.7.1 Yino Pharma Limited Company Information
- 4.7.2 Yino Pharma Limited Business Overview
- 4.7.3 Yino Pharma Limited Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Yino Pharma Limited Heparin Sodium Injection Product Portfolio
- 4.7.5 Yino Pharma Limited Recent Developments
- 4.8 Xinbai Pharmaceuticals
- 4.8.1 Xinbai Pharmaceuticals Company Information
- 4.8.2 Xinbai Pharmaceuticals Business Overview
- 4.8.3 Xinbai Pharmaceuticals Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Xinbai Pharmaceuticals Heparin Sodium Injection Product Portfolio
- 4.8.5 Xinbai Pharmaceuticals Recent Developments
- 4.9 Pharma Action
- 4.9.1 Pharma Action Company Information
- 4.9.2 Pharma Action Business Overview
- 4.9.3 Pharma Action Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Pharma Action Heparin Sodium Injection Product Portfolio
- 4.9.5 Pharma Action Recent Developments
- 4.10 Opocrin
- 4.10.1 Opocrin Company Information
- 4.10.2 Opocrin Business Overview
- 4.10.3 Opocrin Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Opocrin Heparin Sodium Injection Product Portfolio
- 4.10.5 Opocrin Recent Developments
- 4.11 Dongying Tiandong Pharmaceutical
- 4.11.1 Dongying Tiandong Pharmaceutical Company Information
- 4.11.2 Dongying Tiandong Pharmaceutical Business Overview
- 4.11.3 Dongying Tiandong Pharmaceutical Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Dongying Tiandong Pharmaceutical Heparin Sodium Injection Product Portfolio
- 4.11.5 Dongying Tiandong Pharmaceutical Recent Developments
- 4.12 Dongcheng Biochemicals
- 4.12.1 Dongcheng Biochemicals Company Information
- 4.12.2 Dongcheng Biochemicals Business Overview
- 4.12.3 Dongcheng Biochemicals Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Dongcheng Biochemicals Heparin Sodium Injection Product Portfolio
- 4.12.5 Dongcheng Biochemicals Recent Developments
- 4.13 Changshan Biochemical
- 4.13.1 Changshan Biochemical Company Information
- 4.13.2 Changshan Biochemical Business Overview
- 4.13.3 Changshan Biochemical Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Changshan Biochemical Heparin Sodium Injection Product Portfolio
- 4.13.5 Changshan Biochemical Recent Developments
- 4.14 Bioibérica
- 4.14.1 Bioibérica Company Information
- 4.14.2 Bioibérica Business Overview
- 4.14.3 Bioibérica Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Bioibérica Heparin Sodium Injection Product Portfolio
- 4.14.5 Bioibérica Recent Developments
- 4.15 Aspen Oss
- 4.15.1 Aspen Oss Company Information
- 4.15.2 Aspen Oss Business Overview
- 4.15.3 Aspen Oss Heparin Sodium Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Aspen Oss Heparin Sodium Injection Product Portfolio
- 4.15.5 Aspen Oss Recent Developments
5 Global Heparin Sodium Injection Market Scenario by Region
- 5.1 Global Heparin Sodium Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Heparin Sodium Injection Sales by Region: 2021-2032
- 5.2.1 Global Heparin Sodium Injection Sales by Region: 2021-2026
- 5.2.2 Global Heparin Sodium Injection Sales by Region: 2027-2032
- 5.3 Global Heparin Sodium Injection Revenue by Region: 2021-2032
- 5.3.1 Global Heparin Sodium Injection Revenue by Region: 2021-2026
- 5.3.2 Global Heparin Sodium Injection Revenue by Region: 2027-2032
- 5.4 North America Heparin Sodium Injection Market Facts & Figures by Country
- 5.4.1 North America Heparin Sodium Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Heparin Sodium Injection Sales by Country (2021-2032)
- 5.4.3 North America Heparin Sodium Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Heparin Sodium Injection Market Facts & Figures by Country
- 5.5.1 Europe Heparin Sodium Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Heparin Sodium Injection Sales by Country (2021-2032)
- 5.5.3 Europe Heparin Sodium Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Heparin Sodium Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Heparin Sodium Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Heparin Sodium Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Heparin Sodium Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Heparin Sodium Injection Market Facts & Figures by Country
- 5.7.1 South America Heparin Sodium Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Heparin Sodium Injection Sales by Country (2021-2032)
- 5.7.3 South America Heparin Sodium Injection Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Heparin Sodium Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Heparin Sodium Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Heparin Sodium Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Heparin Sodium Injection Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Heparin Sodium Injection Sales by Type (2021-2032)
- 6.1.1 Global Heparin Sodium Injection Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Heparin Sodium Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Heparin Sodium Injection Revenue by Type (2021-2032)
- 6.2.1 Global Heparin Sodium Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Heparin Sodium Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Heparin Sodium Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Heparin Sodium Injection Sales by Application (2021-2032)
- 7.1.1 Global Heparin Sodium Injection Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Heparin Sodium Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Heparin Sodium Injection Revenue by Application (2021-2032)
- 7.2.1 Global Heparin Sodium Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Heparin Sodium Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Heparin Sodium Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Heparin Sodium Injection Value Chain Analysis
- 8.1.1 Heparin Sodium Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Heparin Sodium Injection Production Mode & Process
- 8.2 Heparin Sodium Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Heparin Sodium Injection Distributors
- 8.2.3 Heparin Sodium Injection Customers
9 Global Heparin Sodium Injection Analyzing Market Dynamics
- 9.1 Heparin Sodium Injection Industry Trends
- 9.2 Heparin Sodium Injection Industry Drivers
- 9.3 Heparin Sodium Injection Industry Opportunities and Challenges
- 9.4 Heparin Sodium Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst